World experts present respiratory and critical care research at CHEST 2003, intl scientific assembly

October 08, 2003

(Northbrook, IL, October 7, 2003) World-renowned experts in cardiopulmonary and critical care medicine will present findings on the latest research related to asthma, lung cancer, critical and end-of-life care, COPD, sleep medicine, sepsis, thoracic surgery, tobacco cessation, and other respiratory conditions during CHEST 2003, the multidisciplinary world congress on diseases of the chest, October 25-30, in Orlando, FL.

Thousands of medical professionals will be on hand to learn from national and international experts and up-and-coming investigators as they present more than 600 cutting-edge clinical research abstracts and case reports in various formats, including 175 original scientific sessions, 10 honor lectures, and 30 satellite symposia at the annual international scientific assembly of the American College of Chest Physicians (ACCP). In addition, attendees will have the opportunity for personalized instruction during the 22 postgraduate courses covering a broad range of subspecialty topics, including obstructive sleep apnea, pediatric pulmonology, disaster medicine, pulmonary vascular disease, lung cancer, and critical care.

"CHEST 2003 will gather leaders in the field of chest medicine who will provide a thorough examination of the most current scientific developments in a variety of subspecialties," said Curtis N. Sessler, MD, FCCP, Program Chair, CHEST 2003. "Physicians and other medical professionals will have the opportunity to review the latest in diagnostic procedures, innovative and conventional treatments, and patient care issues." Special events and program highlights for clinical and research topics include: "The CHEST 2003 program will provide new and seasoned medical professionals with a comprehensive overview of the most current advances in pulmonary and critical care medicine," said Udaya B. S. Prakash, MD, FCCP, President of the American College of Chest Physicians. "Whether you're in academia, private practice, or a physician in training, this year's program offers something for everyone in every specialty within the realm of chest medicine."

CHEST 2003 is the 69th annual international scientific assembly of the American College of Chest Physicians, being held in Orlando, October 25-30. ACCP represents more than 15,700 members who provide clinical respiratory, critical care, and cardiothoracic patient care in the United States and throughout the world. ACCP's mission is to promote the prevention and treatment of diseases of the chest through leadership, education, research, and communication.
-end-


American College of Chest Physicians

Related Lung Cancer Articles from Brightsurf:

State-level lung cancer screening rates not aligned with lung cancer burden in the US
A new study reports that state-level lung cancer screening rates were not aligned with lung cancer burden.

The lung microbiome may affect lung cancer pathogenesis and prognosis
Enrichment of the lungs with oral commensal microbes was associated with advanced stage disease, worse prognosis, and tumor progression in patients with lung cancer, according to results from a study published in Cancer Discovery, a journal of the American Association for Cancer Research.

New analysis finds lung cancer screening reduces rates of lung cancer-specific death
Low-dose CT screening methods may prevent one death per 250 at-risk adults screened, according to a meta-analysis of eight randomized controlled clinical trials of lung cancer screening.

'Social smokers' face disproportionate risk of death from lung disease and lung cancer
'Social smokers' are more than twice as likely to die of lung disease and more than eight times as likely to die of lung cancer than non-smokers, according to research presented at the European Respiratory Society International Congress.

Lung cancer therapy may improve outcomes of metastatic brain cancer
A medication commonly used to treat non-small cell lung cancer that has spread, or metastasized, may have benefits for patients with metastatic brain cancers, suggests a new review and analysis led by researchers at St.

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.

Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.

Lung transplant patients face elevated lung cancer risk
In an American Journal of Transplantation study, lung cancer risk was increased after lung transplantation, especially in the native (non-transplanted) lung of single lung transplant recipients.

Proposed cancer treatment may boost lung cancer stem cells, study warns
Epigenetic therapies -- targeting enzymes that alter what genes are turned on or off in a cell -- are of growing interest in the cancer field as a way of making a cancer less aggressive or less malignant.

Are you at risk for lung cancer?
This question isn't only for people who've smoked a lot.

Read More: Lung Cancer News and Lung Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.